secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cibus, Inc. (CBUS)
CIK:        0001705843
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001628280-25-023826
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cibus Q1 net loss $49.4M; cash $23.6M into Q3; evaluates strategic alternatives
-------------------------------------------------------------------------------

- Net loss of $49.4M ($1.34 per share) vs $27.0M a year ago; includes $21.0M non-cash goodwill impairment.
- Cash and cash equivalents $23.6M as of March 31, 2025; expects to fund operations into Q3 2025 without new financing.
- Board and financial advisor evaluating a full range of strategic alternatives to maximize shareholder value.
- Regulatory wins: Ecuador deemed HT1/HT3 rice traits equivalent to conventional; USDA-APHIS classified two canola disease resistance traits as not regulated.
- Rice trait commercialization on track for 2027; customer germplasm integration underway in North and South America.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1705843/000162828025023826/0001628280-25-023826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1705843/000162828025023826/cbus-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-023826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer